Innovative Payment Solutions Announces Availability of MeMD Telemedicine Offering through its IPSIPay® App
Innovative Payment Solutions, Inc. (OTCQB:IPSI) has announced the integration of MeMD, a telemedicine service acquired by Walmart, into its IPSIPay® app. This addition aims to provide healthcare access to unbanked and underserved communities, enhancing the app's utility. With around five million users, MeMD offers services including urgent and behavioral health care. IPSI's CEO, William Corbett, emphasized the significance of this service for improving users' quality of life.
- Integration of MeMD telemedicine service into the IPSIPay® app to improve healthcare access for users.
- Access to a wide range of services including urgent care and mental health support through a well-established platform.
- Potential to enhance user engagement and retention with valuable health services.
- Risks associated with the commercialization of the IPSIPay® app and consumer adoption.
- Dependence on technology and platform stability for successful service delivery.
- Uncertainties related to revenue generation and profitability amid the ongoing economic impacts of COVID-19.
IPSI continues its efforts to build its IPSIPay® super app providing financial and other services to support unbanked and underserved communities
CARMEL BY THE SEA, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Innovative Payment Solutions, Inc. (OTCQB:IPSI) (“IPSI” or the “Company”), a fintech provider of digital payment and other solutions to both business owners and consumers, today announces the availability of MeMD (also known as Walmart Health Virtual Care), providing a comprehensive telemedicine offering via the Company’s IPSIPay® app.
Founded in 2010 and acquired by Walmart in 2021, MeMD is a leading provider of around-the-clock telemedicine and mental health care services with five million users nationwide. IPSIPay® mobile app users will now have access to highly qualified, licensed healthcare providers using MeMD to address their healthcare needs in a thorough, expedited, and privacy compliant manner. MeMD services can help address many common medical issues, as well as remote access behavioral health services for emotional and mental health concerns. Its offerings include urgent care, men’s health, women’s health, talk therapy, teen therapy and psychiatry.
William Corbett, IPSI’s Chairman and Chief Executive Officer, commented "The MeMD telemedicine platform is an important addition to the offerings on our IPSIPay® app as it provides our users with access to quality healthcare services in a manner that is fast, convenient, cost effective, and privacy compliant. As we focus on the needs of the unbanked and underserved who often lack access to the types of solutions we offer, this telemedicine offering is an important service that has the potential to improve the quality of life of users in our target market. We also believe it will continue to solidify the utility of IPSIPay® for these users as a one-stop resource to access many of their daily needs.”
About Innovative Payment Solutions, Inc.
Innovative Payment Solutions, Inc. (OTCQB:IPSI) is a cutting-edge provider of digital payment and other solutions for both business owners and consumers, focusing on the needs of the unbanked and underserved. Through its IPSIPay® App and Beyond Wallet offerings, IPSI facilitates instantaneous cross-border remittances by companies and individuals, using its robust technology platform to enable digital transactions that are convenient, cost effective, fast, and secure. IPSIPay® App users can acquire VISA debit cards, as well as obtain a bank account at a major U.S. institution, enabling them to execute financial transactions through IPSI’s large, worldwide merchant network.
To learn more about Innovative Payment Solutions, Inc., please visit www.ipsipay.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 made by Company management and the Company’s commercial collaborators. All statements other than statements of historical fact contained in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate, “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” or “will” or the or the negative of these terms or other comparable terminology. These forward-looking statements are based on expectations and assumptions as of the date of the press release and are subject to significant risks and uncertainties, many of which are difficult to predict that could cause actual results (including the anticipated benefits of the MeMD offering through the IPSIPay® App) to differ materially and adversely from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others: (i) the Company’s ability to continue its commercialization efforts for the IPSIPay® App and related capabilities, such as the MeMD offering; (ii) the Company’s ability to increase its number of users; (iii) the Company’s ability to operate its platform without errors; (iv) the Company’s ability to operate its technology for use in all U.S. states and foreign countries; (v) the Company’s ability to generate revenue, positive cash flow or profitability; (vi) the duration and scope of the COVID-19 pandemic worldwide (which has delayed the launch of IPSIPay®), including the impact to the economy in California and Mexico; and (vii) the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, and the Company’s subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release. The Company undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Media Inquiries
CORE IR
Jules Abraham
917-885-7378
julesa@coreir.com
Investor Inquiries
Tel: (866) 477-4729
investors@ipsipay.com
FAQ
What new features has IPSI added to its IPSIPay app?
How does IPSIPay address the needs of unbanked communities?
What type of services does MeMD offer through IPSIPay?
What are the potential risks associated with IPSI’s new telemedicine offering?
When was IPSI's press release about MeMD issued?
